TrialPanorama/TrialPanorama-database huggingface dataset:
Study 12085979 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7866911 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study 7866911 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 22220945 — Predictive Biomarker (PRD): DMTN mRNA
Genes: DMTN; DMT; EPB49
Study 10049274 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7577484 — Surrogate Endpoint (SUR): Serum calcium
Study 24634622 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24634622 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 24634622 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24634622 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 24634622 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 21952002 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12060421 — Surrogate Endpoint (SUR): Bacterial count
Study 29609921 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23393217 — Surrogate Endpoint (SUR): Blood pressure
Study 22815422 — Surrogate Endpoint (SUR): Blood pressure
Study 15977870 — Surrogate Endpoint (SUR): Blood pressure
Study 23946220 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 23946220 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23946220 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23946220 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23946220 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 16874005 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study 16874005 — Predictive Biomarker (PRD): HTR3A mRNA
Genes: HTR3A; 5HT3R; HTR3
Study 15257469 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 15257469 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 9407327 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 8516523 — Surrogate Endpoint (SUR): Blood pressure
Study 3044238 — Surrogate Endpoint (SUR): Blood pressure
Study 7873457 — Predictive Biomarker (PRD): Hormone receptor
Study 1445483 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 26759167 — Predictive Biomarker (PRD): MCCC2 mRNA
Genes: MCCC2; MCCB
Study 24626147 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 22007690 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22007690 — Surrogate Endpoint (SUR): Blood pressure
Study 20214496 — Surrogate Endpoint (SUR): Blood pressure
Study 11464257 — Surrogate Endpoint (SUR): Blood pressure
Study 9681128 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 9681128 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26063890 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 21558577 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 31382292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24168756 — Predictive Biomarker (PRD): CD83 mRNA
Genes: CD83
Study 24168756 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 8881869 — Surrogate Endpoint (SUR): Blood pressure
Study 10444434 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 7483181 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 27229348 — Predictive Biomarker (PRD): MT2A mRNA
Genes: MT2A; CES1; MT2
Study 20499349 — Surrogate Endpoint (SUR): Bone mineral density
Study 11011338 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 8803378 — Predictive Biomarker (PRD): SRM mRNA
Genes: SRM; SPS1; SRML1
Study 28506134 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20651609 — Predictive Biomarker (PRD): SLC19A1 mRNA
Genes: SLC19A1; FLOT1; RFC1
Study 20651609 — Predictive Biomarker (PRD): GGH mRNA
Genes: GGH
Study 16305652 — Surrogate Endpoint (SUR): Blood pressure
Study 19925284 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19925284 — Surrogate Endpoint (SUR): Blood pressure
Study 25026506 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 31925529 — Predictive Biomarker (PRD): TRIM63 mRNA
Genes: TRIM63; IRF; MURF1; RNF28; SMRZ
Study 16500921 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 11396393 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 28755607 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 28755607 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20827547 — Surrogate Endpoint (SUR): Bone mineral density
Study 870096 — Surrogate Endpoint (SUR): Blood pressure
Study 31500605 — Predictive Biomarker (PRD): PAICS mRNA
Genes: PAICS; ADE2; AIRC; PAIS
Study 31500605 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 31500605 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 26952317 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 12231595 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7864425 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7864425 — Surrogate Endpoint (SUR): Blood pressure
Study 20857093 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 20857093 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 24692816 — Surrogate Endpoint (SUR): Blood pressure
Study 16793604 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16793604 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16793604 — Safety Biomarker (SAF): IL-6 and IL-10
Study 9143790 — Surrogate Endpoint (SUR): Blood pressure
Study 30732506 — Surrogate Endpoint (SUR): Serum creatinine
Study 28651370 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 27737719 — Surrogate Endpoint (SUR): Blood pressure
Study 22007645 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15080375 — Surrogate Endpoint (SUR): Blood pressure
Study 31662352 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 31662352 — Predictive Biomarker (PRD): CES2 mRNA
Genes: CES2; ICE
Study 29156912 — Predictive Biomarker (PRD): NBPF1 mRNA
Genes: NBPF1; KIAA1693
Study 29156912 — Predictive Biomarker (PRD): DNM2 mRNA
Genes: DNM2; DYN2
Study 29156912 — Predictive Biomarker (PRD): TSEN54 mRNA
Genes: TSEN54; SEN54
Study 29156912 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study 29156912 — Predictive Biomarker (PRD): UGT2A1 mRNA
Genes: UGT2A1
Study 29156912 — Predictive Biomarker (PRD): VLDLR mRNA
Genes: VLDLR
Study 29156912 — Predictive Biomarker (PRD): SEC23A mRNA
Genes: SEC23A
Study 29156912 — Predictive Biomarker (PRD): HAS1 mRNA
Genes: HAS1; HAS
Study 29156912 — Predictive Biomarker (PRD): ADAMTS16 mRNA
Genes: ADAMTS16; KIAA2029
Study 12020142 — Surrogate Endpoint (SUR): Bone mineral density
Study 31778431 — Safety Biomarker (SAF): Hyaluronic acid
Study 28351393 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28351393 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 28351393 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11720199 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 22894624 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 22894624 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12054161 — Surrogate Endpoint (SUR): Bone mineral density
Study 22042106 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 18450596 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 7762523 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 7762523 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25970149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25970149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25970149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23439424 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 19101496 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 9308762 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9308762 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 28326681 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 16649186 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 19793849 — Surrogate Endpoint (SUR): Blood pressure
Study 20039197 — Surrogate Endpoint (SUR): Blood pressure
Study 18772275 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23082447 — Safety Biomarker (SAF): DRD2
Study 17868242 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 16868976 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 12534315 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12534315 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12534315 — Surrogate Endpoint (SUR): Serum triglycerides
Study 10649617 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study 8783388 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 19584979 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19584979 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7004273 — Surrogate Endpoint (SUR): Serum potassium
Study 21382868 — Surrogate Endpoint (SUR): Pathological complete response
Study 3259100 — Surrogate Endpoint (SUR): Blood pressure
Study 26583660 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 17319450 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 17353316 — Predictive Biomarker (PRD): MTR mRNA
Genes: MTR
Study 28941607 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 26571421 — Surrogate Endpoint (SUR): Serum uric acid
Study 26571421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23416142 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 31754133 — Predictive Biomarker (PRD): PPP3R1 mRNA
Genes: PPP3R1; CNA2; CNB
Study 25145487 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17925486 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 30570938 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27090108 — Predictive Biomarker (PRD): DDT mRNA
Genes: DDT
Study 16503695 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 12948274 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18675744 — Surrogate Endpoint (SUR): Blood pressure
Study 8410120 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 30786916 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 30786916 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 11930332 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9452835 — Surrogate Endpoint (SUR): Bone mineral density
Study 21251985 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 19117313 — Surrogate Endpoint (SUR): Blood pressure
Study 15247553 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15247553 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3326634 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 16306217 — Surrogate Endpoint (SUR): Blood pressure
Study 28681171 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study 28681171 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 27188987 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 27188987 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26068323 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17705186 — Monitoring Biomarker (MOI): HBV DNA
Study 31090170 — Monitoring Biomarker (MOI): HBV DNA
Study 30736781 — Surrogate Endpoint (SUR): Blood pressure
Study 28499715 — Surrogate Endpoint (SUR): Blood pressure
Study 31051059 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31051059 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 29314138 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 11530400 — Surrogate Endpoint (SUR): Blood pressure
Study 23496876 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 21493747 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 12548082 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10911780 — Surrogate Endpoint (SUR): Blood pressure
Study 3891203 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 3891203 — Surrogate Endpoint (SUR): Serum creatinine
Study 24906587 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18479954 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 1951831 — Surrogate Endpoint (SUR): Blood pressure
Study 25527737 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 25527737 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 11762561 — Surrogate Endpoint (SUR): Blood pressure
Study 10322845 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10322845 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7679040 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 25761833 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 25761833 — Surrogate Endpoint (SUR): Blood pressure
Study 18785569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18785569 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 18785569 — Safety Biomarker (SAF): IL-6 and IL-10
Study 23980044 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 19661049 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 19661049 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10340958 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22009916 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 19560695 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 19560695 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 16480759 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 31923642 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 27780932 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 27780932 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 27780932 — Safety Biomarker (SAF): Platelet to lymphocyte
Study 26419096 — Surrogate Endpoint (SUR): Blood pressure
Study 21844885 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 21844885 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25645325 — Surrogate Endpoint (SUR): Blood pressure
Study 22052313 — Predictive Biomarker (PRD): FGF7 mRNA
Genes: FGF7; KGF
Study 22052313 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 12231656 — Predictive Biomarker (PRD): VCP mRNA
Genes: VCP
Study 19390585 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 11313175 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 3131387 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 17266689 — Monitoring Biomarker (MOI): HBV DNA
Study 15519189 — Surrogate Endpoint (SUR): Blood pressure
Study 25753493 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25753493 — Surrogate Endpoint (SUR): Blood pressure
Study 17940987 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 31240310 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 22017530 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 22017530 — Surrogate Endpoint (SUR): Blood pressure
Study 24762259 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17949786 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 17949786 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study 17949786 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17949786 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 7491373 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 8729093 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30882234 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 24582547 — Predictive Biomarker (PRD): CNR1 mRNA
Genes: CNR1; CNR
Study 17494881 — Surrogate Endpoint (SUR): Serum creatinine
Study 17494881 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1092420 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31425700 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 31425700 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31425700 — Safety Biomarker (SAF): BDNF
Study 26728611 — Predictive Biomarker (PRD): RUNX1T1 mRNA
Genes: RUNX1T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2
Study 22230651 — Safety Biomarker (SAF): DRD2
Study 7648705 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7648705 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 24386952 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 18372700 — Surrogate Endpoint (SUR): Blood pressure
Study 565418 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 29315160 — Surrogate Endpoint (SUR): Serum calcium
Study 18440702 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 16188050 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 10435730 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 28639118 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19347033 — Surrogate Endpoint (SUR): Blood pressure
Study 11052441 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 3164442 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 30262148 — Surrogate Endpoint (SUR): Blood pressure
Study 12816263 — Surrogate Endpoint (SUR): Blood pressure
Study 19463517 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23214247 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 17515572 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 16135575 — Surrogate Endpoint (SUR): Blood pressure
Study 10458713 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7541660 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 31087723 — Predictive Biomarker (PRD): SLC6A3 mRNA
Genes: SLC6A3; DAT1
Study 31087723 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 28871440 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 26475215 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26475215 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 26475215 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 14569279 — Surrogate Endpoint (SUR): Blood pressure
Study 2437789 — Surrogate Endpoint (SUR): Blood pressure
Study 1769635 — Surrogate Endpoint (SUR): Blood pressure
Study 31479003 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 26470711 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study 16965680 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 8993241 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 31944310 — Surrogate Endpoint (SUR): Blood pressure
Study 31944310 — Pharmacodynamic Biomarker (PDY): Dermal blood flow
Study 12792297 — Surrogate Endpoint (SUR): Bone mineral density
Study 1459154 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 1459154 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 6695853 — Predictive Biomarker (PRD): TNR mRNA
Genes: TNR
Study 29550383 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study 29550383 — Predictive Biomarker (PRD): MAPK1 mRNA
Genes: MAPK1; ERK2; PRKM1; PRKM2
Study 24625583 — Surrogate Endpoint (SUR): Serum creatinine
Study 20214755 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4